President Donald Trump’s administration introduced that Medicare can pay diminished costs for 15 prescribed drugs, together with weight-loss and most cancers medicines.
On Tuesday, the Centers for Medicare & Medicaid Services revealed that the diminished drug costs are anticipated to avoid wasting the federal government about $12 billion on Medicare spending in contrast with final yr.
“President Trump directed us to stop at nothing to lower health care costs for the American people,” Health and Human Services Secretary Robert F. Kennedy, Jr. mentioned in a information launch. “As we work to Make America Healthy Again, we will use every tool at our disposal to deliver affordable health care to seniors.”
The new “maximum fair prices” for the medicine will take impact on January 1, 2027, elevating the whole variety of medicines with negotiated costs to 25 when added to the ten introduced by former President Joe Biden’s administration final yr.
“This year’s results stand in stark contrast to last year’s,” CMS Administrator Mehmet Oz mentioned. “Using the same process with a bolder direction, we have achieved substantially better outcomes for taxpayers.”
Among the medicine included in this system are weight-loss medicine Ozempic and Wegovy and most cancers medicine Xtandi, Pomalyst, Ibrance.
Trelegy Ellipta, Offering, Links, Calquence, Austedo XR, Breos Ellipta, Tradjeta, Xifaxan, Vraylar, Janumet and Janumet XR and Otezla.
https://www.independent.co.uk/news/world/americas/us-politics/ozempic-cancer-drugs-lower-prices-medicaid-b2872900.html